Evidence map›Paper›PMID 30899600›Full record

ArticleNature biomedical engineering2019

Genome-edited skin epidermal stem cells protect mice from cocaine-seeking behaviour and cocaine overdose.

Yuanyuan Li, Qingyao Kong, Jiping Yue, Xuewen Gou, Ming Xu, Xiaoyang Wu

Abstract read
In one paragraph

Article in Nature biomedical engineering, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. NThe EMBO journal · 2021
    Article
  12. Article
  13. Article
  14. Review
  15. Henceforth CRISPR.Nature biomedical engineering · 2020
    Article
  16. Article
  17. Article
  18. Review
  19. Opioid Addiction, Genetic Susceptibility, and Medical Treatments: A Review.International journal of molecular sciences · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yuanyuan Li *Ben May Department for Cancer Research, University of Chicago, Chicago, IL, USA.
Qingyao Kong *Department of Anesthesia and Critical Care, University of Chicago, Chicago, IL, USA.
Jiping YueBen May Department for Cancer Research, University of Chicago, Chicago, IL, USA.
Xuewen GouBen May Department for Cancer Research, University of Chicago, Chicago, IL, USA.
Ming XuDepartment of Anesthesia and Critical Care, University of Chicago, Chicago, IL, USA. mxu@dacc.uchicago.edu.ORCID http://orcid.org/0000-0001-9595-834X
Xiaoyang WuBen May Department for Cancer Research, University of Chicago, Chicago, IL, USA. xiaoyangwu@uchicago.edu.ORCID http://orcid.org/0000-0001-6378-3207
University of Chicago · US

Funding

Re-Engineering Translational Research at the University of ChicagoUL1TR000430 · NCATS · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2012 to 2016
$20.2M
Multi-Disciplinary Training Grant in Cancer ResearchT32CA009594 · NCI · UNIVERSITY OF CHICAGO · PI KAY F MACLEOD, Scott A. Oakes · 1989 to 2026
$11.5M
RNA methylation in synaptic plasticity and drug-seekingR01DA043361 · NIDA · UNIVERSITY OF CHICAGO · PI ZHUANG, XIAOXI · 2017 to 2021
$2.8M
Development of epidermal progenitor cell-based therapy for regenerative medicineR01OD023700 · OD · UNIVERSITY OF CHICAGO · PI WU, XIAOYANG · 2017 to 2021
$2.4M
Coordinated cytoskeletal dynamics in skin somatic stem cells - Resubmission 01R01AR063630 · NIAMS · UNIVERSITY OF CHICAGO · PI WU, XIAOYANG · 2013 to 2017
$1.7M
A novel tool for studying D3 receptors and cocaine rewardR21DA036921 · NIDA · UNIVERSITY OF CHICAGO · PI XU, MING · 2015 to 2016
$432k
NCATS NIH HHS UL1 TR000430NCI NIH HHS T32 CA009594NIAMS NIH HHS R01 AR063630NIDA NIH HHS R01 DA043361NIDA NIH HHS R21 DA036921NIH HHS R01 OD023700
6 · The paper itself

Abstract

Cocaine addiction is associated with compulsive drug-seeking, and exposure to the drug or to drug-associated cues leads to relapse, even after long periods of abstention. A variety of pharmacological targets and behavioral interventions have been explored to counteract cocaine addiction, but to date no market-approved medications for treating cocaine addiction or relapse exist, and effective interventions for acute emergencies resulting from cocaine overdose are lacking. We recently demonstrated that skin epidermal stem cells can be readily edited by using CRISPR (clustered regularly interspaced short palindromic repeats) and then transplanted back into the donor mice. Here, we show that the transplantation, into mice, of skin cells modified to express an enhanced form of butyrylcholinesterase, an enzyme that hydrolyzes cocaine, enables the long-term release of the enzyme and efficiently protects the mice from cocaine-seeking behavior and cocaine overdose. Cutaneous gene therapy through skin transplants that elicit drug elimination may offer a therapeutic option to address drug abuse.

Identifiers

PMID30899600
PMCPMC6423967
OpenAlexW2890253037

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.